Deals That Grow Companies
hero_pattern.png

BC Burr McCabe Law

Deals That Grow Companies.

 

Helping biotech, software and technology companies with growth-oriented transactions.

B C Burr McCabe Law specializes in helping biotech, software and technology companies with growth-oriented transactions.

The firm was founded by lawyers with successful careers at multi-national law firms who provide responsive service by focusing on a small number of clients. We cultivate fewer, more in-depth, client relationships, providing each client more attention from highly skilled partner-level practitioners.

Our clients are leaders in their industries confronting complex licensing, distribution and commercialization deals. We leverage decades of experience with these transactions to help our clients succeed.

 

☎ CONTACT

Brian Burr
(415) 285-8500
bcburr@bcbmlaw.com

☎ CONTACT

Peter McCabe
(925) 586-1468
pmccabe@bcbmlaw.com


M&A Transactions


Wisdomforce

Represented WisdomForce Technologies, Inc., an innovator of low impact, high throughput data replication technology, in the sale of all its stock to Informatica Corporation.

salesforce

Represented Salesforce.com in the acquisition of all the stock of a San Francisco-based software company.

Amalyte

Represented Amalyte Pharmaceuticals Inc., a biopharmaceutical company developing novel therapies for the treatment of immune and inflammatory diseases, in the sale of all its assets to Kemin Industries, Inc.

Wind river systems

Represented Wind River Systems Inc. in support of its asset acquisition of RTLinux real-time Linux technology.

KenLet

Represented Kenlet LLC in the sale of its assets to Salesforce.com, including websites formerly known as crispynews.com and crispyideas.com, which provided solutions to permit companies to create interactive forums for promoting, creating and evaluating ideas internally.

Technology Transactions


Altor Bioscience

Represented Altor BioScience Corporation (“Altor”) in an Exclusive License Agreement with Genentech, Inc. for exclusive, worldwide rights to develop and commercialize a class of antibody-based Tissue Factor antagonists.

CIRM

Represented the California Institute of Regenerative Medicine (“CIRM”), in a license and professional services transaction with Grantium Inc. for the implementation of an enterprise grant management solution. CIRM is the agency established in 2005 under the Stem Cell Research and Cures Initiative to make grants and provide loans for stem cell research.

Software as a service

On-going representation of several cloud-based solution companies and SaaS companies in customer subscription license transactions.